Potential of longitudinal data from single site and multi-center clinical trials for AI-research

Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he received when sharing the mint report for the first time, how patients benefit from the longitudinal overview of disease, and his plans to use the structured data for AI research.

Related Resources

Related Resources

MROC: The Impact of mpMRI on the Staging and Management of Patients with Suspected or Confirmed OC

Funded by the National Institute of Health Research (NIHR) and sponsored by the Imperial College London, the MROC study boasts impressive figures: 645…

AI-powered quantification of bone metastasis in prostate cancer

Prostate cancer is the second most common cancer among men, and there are now effective treatments for the disease. New therapies available on the…

Radiomics - the next era of possibilities in Precision Medicine

Traditionally medical image analysis has been done through visual interpretation of static images. In the past decade, with the advent of…